诱导雄激素剥夺治疗后T4前列腺癌根治性前列腺切除术:单中心长期随访结果
本研究回顾性分析116例初诊为T4前列腺癌(因直肠指检固定肿块合并高PSA和/或大灶未分化癌而视为不可手术)患者,接受诱导ADT至PSA最低点后行根治性前列腺切除术。中位OS为156个月,150个月时前列腺癌特异性生存率为82%,提示诱导ADT后手术可行且安全。
要点
- T4前列腺癌经诱导ADT至PSA最低点后行RP可行且安全。
- 中位OS为156个月,150个月PCSS为82%。
- 诱导ADT后手术的OS似与初诊可手术高危前列腺癌相当。
核心结论
- 初诊不可手术的T4前列腺癌在诱导ADT后行手术治疗是可行且安全的。
- 该队列的OS似乎与初诊可手术高危前列腺癌患者的结果相当。
研究设计与样本
- 单中心回顾性研究,查询根治性前列腺切除术数据库。
- 纳入2000年至2014年间初诊为T4前列腺癌的116例患者。
- 治疗为先行ADT直至PSA最低点(通常6-7个月),随后行耻骨后RP或机器人辅助腹腔镜RP。
主要发现
- 诊断时中位PSA为37.6 ng/mL(范围2.44-284)。
- 诱导ADT后术前中位PSA为0.73 ng/mL(范围0.01-34)。
- 中位OS为156个月(95%CI 118.9-193.1)。
- 150个月时PCSS为82%。
临床怎么用
- 对于初诊不可手术的T4前列腺癌,可考虑诱导ADT至PSA最低点后行根治性前列腺切除术。
- 手术方式可选择耻骨后RP或机器人辅助腹腔镜RP。
局限性
- 单中心回顾性研究。
- 样本量有限(116例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. PATIENTS AND METHODS: A monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7 months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). RESULTS: We retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150 months was 82%. CONCLUSIONS: Surgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
- Hajili T, Ohlmann CH, Linxweiler J, et al. Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up. BJU Int. 2018. PMID: 29772100. doi:10.1111/bju.14393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。